These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 25862448)

  • 1. Evaluation of human papilloma virus (HPV) vaccination strategies and vaccination coverage in adolescent girls worldwide.
    Owsianka B; Gańczak M
    Przegl Epidemiol; 2015; 69(1):53-8, 151-5. PubMed ID: 25862448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlates of human papillomavirus vaccine coverage: a state-level analysis.
    Moss JL; Reiter PL; Brewer NT
    Sex Transm Dis; 2015 Feb; 42(2):71-5. PubMed ID: 25585064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007-2016.
    Gallagher KE; Howard N; Kabakama S; Mounier-Jack S; Burchett HED; LaMontagne DS; Watson-Jones D
    Papillomavirus Res; 2017 Dec; 4():72-78. PubMed ID: 29179873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries.
    Goldie SJ; O'Shea M; Campos NG; Diaz M; Sweet S; Kim SY
    Vaccine; 2008 Jul; 26(32):4080-93. PubMed ID: 18550229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness and equity impacts of three HPV vaccination programmes for school-aged girls in New Zealand.
    Blakely T; Kvizhinadze G; Karvonen T; Pearson AL; Smith M; Wilson N
    Vaccine; 2014 May; 32(22):2645-56. PubMed ID: 24662710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV vaccination in France: uptake, costs and issues for the National Health Insurance.
    Fagot JP; Boutrelle A; Ricordeau P; Weill A; Allemand H
    Vaccine; 2011 Apr; 29(19):3610-6. PubMed ID: 21382486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic human papillomavirus vaccination and primary prevention of cervical cancer: issues and challenges.
    Poljak M
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():64-9. PubMed ID: 22862799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inter-state variation in human papilloma virus vaccine coverage among adolescent girls in the 50 US states, 2007.
    Kramer MR; Dunlop AL
    Matern Child Health J; 2012 Apr; 16 Suppl 1():S102-10. PubMed ID: 22453332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges.
    Msyamboza KP; Mwagomba BM; Valle M; Chiumia H; Phiri T
    BMC Public Health; 2017 Jun; 17(1):599. PubMed ID: 28651574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.
    Berkhof J; Bogaards JA; Demirel E; Diaz M; Sharma M; Kim JJ
    Vaccine; 2013 Dec; 31 Suppl 7():H71-9. PubMed ID: 24332299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus vaccine introduction--the first five years.
    Markowitz LE; Tsu V; Deeks SL; Cubie H; Wang SA; Vicari AS; Brotherton JM
    Vaccine; 2012 Nov; 30 Suppl 5():F139-48. PubMed ID: 23199957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Papillomavirus Vaccination Coverage Among School Girls in a Demonstration Project - Botswana, 2013.
    Raesima MM; Forhan SE; Voetsch AC; Hewitt S; Hariri S; Wang SA; Pelletier AR; Letebele M; Pheto T; Ramogola-Masire D; El-Halabi S
    MMWR Morb Mortal Wkly Rep; 2015 Oct; 64(40):1147-9. PubMed ID: 26468997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lessons learnt during the national introduction of human papillomavirus (HPV) vaccination programmes in 6 African countries: Stakeholders' perspectives.
    Abdullahi LH; Hussey GD; Wiysonge CS; Kagina BM
    S Afr Med J; 2020 May; 110(6):525-531. PubMed ID: 32880566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA).
    Kim JJ; Sharma M; O'Shea M; Sweet S; Diaz M; Sancho-Garnier H; Seoud M
    Vaccine; 2013 Dec; 31 Suppl 6():G65-77. PubMed ID: 24331822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Literature review of HPV vaccine delivery strategies: considerations for school- and non-school based immunization program.
    Paul P; Fabio A
    Vaccine; 2014 Jan; 32(3):320-6. PubMed ID: 24295804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in Human Papillomavirus Vaccination Among Adolescent Girls in Metropolitan Versus Non-metropolitan Areas: Considering the Moderating Roles of Maternal Socioeconomic Status and Health Care Access.
    Monnat SM; Rhubart DC; Wallington SF
    Matern Child Health J; 2016 Feb; 20(2):315-25. PubMed ID: 26511129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of human papillomavirus immunization in the developing world.
    Kane MA; Serrano B; de Sanjosé S; Wittet S
    Vaccine; 2012 Nov; 30 Suppl 5():F192-200. PubMed ID: 23199963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel method to value real options in health care: the case of a multicohort human papillomavirus vaccination strategy.
    Favato G; Baio G; Capone A; Marcellusi A; Saverio Mennini F
    Clin Ther; 2013 Jul; 35(7):904-14. PubMed ID: 23806328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV Vaccinations in Lublin Region, Poland.
    Kalinowski P; Grządziel A
    Postepy Hig Med Dosw (Online); 2017 Feb; 71(0):92-97. PubMed ID: 28258669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Argentina's Successful Implementation Of A National Human Papillomavirus Vaccination Program.
    Patel H; Wilson E; Vizzotti C; Parston G; Prestt J; Darzi A
    Health Aff (Millwood); 2016 Feb; 35(2):301-8. PubMed ID: 26858384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.